536
Views
0
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Manifesto on inhaled triple therapy in asthma: an Interasma (Global Asthma Association – GAA) document

, MDORCID Icon, , MD, PhDORCID Icon, , MD, PhD(c)ORCID Icon, , MD, , MD, , MD, PhD, , MD, PhD, , MD, PhD, , MDORCID Icon, , MD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, , MD, , MD, , MD, PhD, , MD, , MD, PhD, , MD, , MD, PhD, , MD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhDORCID Icon, , MD, PhD, , MD & , MD, PhD show all
Pages 2402-2412 | Received 07 Nov 2021, Accepted 20 Dec 2021, Published online: 11 Jan 2022
 

Abstract

Objective: The optimal use of drug combinations for the management of asthma is providing significant results. This has prompted Interasma (Global Asthma Association) to take a position on inhaled triple therapy in asthma.Methods: We performed an extensive literature research to clinical trials, meta-analyses, randomized controlled trials and systematic reviews.Results: Starting from an extensive literature review, Interasma executive committee discussed and approved this Manifesto, developed by Interasma scientific network (INES) members.Conclusions: The manifesto describes the evidence gathered to date and states, advocates, and proposes issues on inhaled corticosteroid (ICS) plus long-acting beta 2 agonist (LABA) and long-acting muscarinic antagonists (LAMA) with the aim of challenging assumptions, fostering commitment, and bringing about change.

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.